Stock listing

NASDAQ:GTHX G1 Therapeutics Inc Stock

Follow G1 Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:GTHX

$7.15 USD

Close on Sep 17, 2024 · No longer trades

May 17, 2017 to last close -52.3% · weekly closes, May 17, 2017 – Sep 17, 2024
Lowest – highest close
$1.12 – $67.97 USDSince May 17, 2017 · lowest Oct 9, 2023 · highest Sep 13, 2018

Delisted NASDAQ:GTHX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:GTHX
Asset type
Stock
Exchange
NASDAQ
Currency
USD

G1 Therapeutics Inc on 6ix

Calls
14 calls with a replay · 14 with a transcript · latest May 1, 2024
Decks
9 decks · latest Jan 8, 2024

Events

CallWhenStatus
G1 Therapeutics (GTHX) Q1 2024 Earnings CallWed, May 01, 2024 · 8:30 AM ETReplay
G1 Therapeutics (GTHX) Q4 2023 Earnings CallWed, Feb 28, 2024 · 8:30 AM ETReplay
G1 Therapeutics (GTHX) Q3 2023 Earnings CallWed, Nov 01, 2023 · 8:30 AM ETReplay
G1 Therapeutics (GTHX) Q2 2023 Earnings CallWed, Aug 02, 2023 · 8:30 AM ETReplay
G1 Therapeutics (GTHX) Q1 2023 Earnings CallWed, May 03, 2023 · 8:30 AM ETReplay
G1 Therapeutics (GTHX) Q4 2022 Earnings CallWed, Mar 01, 2023 · 8:30 AM ETReplay
G1 Therapeutics (GTHX) Q3 2022 Earnings CallWed, Nov 02, 2022 · 8:30 AM ETReplay
G1 Therapeutics (GTHX) Q2 2022 Earnings CallWed, Aug 03, 2022 · 8:30 AM ETReplay
G1 Therapeutics (GTHX) Q1 2022 Earnings CallWed, May 04, 2022 · 8:30 AM ETReplay
G1 Therapeutics (GTHX) Q4 2021 Earnings CallWed, Feb 23, 2022 · 8:30 AM ETReplay
All 14 calls
CallWhenStatus
G1 Therapeutics (GTHX) Q3 2021 Earnings CallWed, Nov 03, 2021 · 8:30 AM ETReplay
G1 Therapeutics (GTHX) Q2 2021 Earnings CallWed, Aug 04, 2021 · 4:30 PM ETReplay
G1 Therapeutics (GTHX) Q1 2021 Earnings CallWed, May 05, 2021 · 4:30 PM ETReplay
G1 Therapeutics (GTHX) Q4 2020 Earnings CallWed, Feb 24, 2021 · 4:30 PM ETReplay

Open Events

Decks

DeckKindSlidesDate
42nd Annual J.P. Morgan Healthcare Conference (January 2024)Conference31 slidesJan 8, 2024
41st Annual J.P. Morgan Healthcare Conference (January 2023)Conference37 slidesJan 9, 2023
40th Annual J.P. Morgan Healthcare Conference 2022Conference32 slidesJan 10, 2022
Investor Presentation (February 2021)Investor deck38 slidesFeb 16, 2021
39th Annual J.P. Morgan Healthcare Conference 2021Conference34 slidesJan 11, 2021
38th Annual J.P. Morgan Healthcare Conference (January 2020)Conference31 slidesJan 13, 2020
Investor Day (October 2019)Investor day58 slidesOct 1, 2019
Investor Presentation (November 2017)Investor deck42 slidesNov 13, 2017
Wedbush PacGrow Healthcare Conference 2017Conference41 slidesAug 17, 2017

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Alicia Secor
Other companies: Zevra Therapeutics, Inc. (Director, Audit Committee, Compensation Committee · Since at least Dec 2, 2025); Orchard Therapeutics PLC (Director · Jan 1, 2020 – Jan 24, 2024 · Past); GW Pharmaceuticals plc (Director · Oct 1, 2018 – May 5, 2021 · Past); Juniper Pharmaceuticals Inc (President and CEO, Director · Aug 1, 2016 – Aug 14, 2018 · Past); Larimar Therapeutics, Inc. (Chief Commercial Officer · Mar 31, 2016 – Mar 31, 2016 · Past)
Director · Jun 17, 2021 – Sep 18, 2024 · Past
Garry A Nicholson
Other companies: TScan Therapeutics, Inc. (Director · Since at least Jun 12, 2024); Day One Biopharmaceuticals Inc (Director · Since at least Sep 12, 2022); NextCure, Inc. (Director · Jun 24, 2021 – Jun 22, 2023 · Past); Turning Point Therapeutics Inc (Director · Jun 2, 2021 – Aug 17, 2022 · Past); Five Prime Therapeutics Inc (Director · Apr 16, 2021 – Apr 16, 2021 · Past)
Director · Jun 17, 2021 – Sep 18, 2024 · Past
Glenn P. Muir
Other companies: Cytek Biosciences, Inc. (Director · Since at least Jun 10, 2026); Neuronetics, Inc. (Board Member · Since at least Jun 27, 2018); Repligen Corporation (Director · Since at least Sep 14, 2015); Lifeward Ltd. (Director · Dec 31, 2015 – Jun 27, 2017 · Past); Hologic Inc (Executive VP and CFO · Feb 1, 2006 – May 8, 2014 · Past)
Director · May 16, 2017 – Sep 18, 2024 · Past
Willie A Deese
Other companies: Public Service Enterprise Group Incorporated (Director · Since at least Feb 16, 2016); Dentsply Sirona Inc. (Director · Since at least Feb 11, 2011); CDK Global Holdings LLC (Director · Sep 29, 2014 – Jul 6, 2022 · Past); Merck & Company, Inc. (Exe V-P & Pres. MMD · Nov 3, 2009 – Feb 22, 2016 · Past)
Director · Jun 7, 2018 – Jun 23, 2022 · Past
Tyrell J. Rivers
Other companies: ADC Therapeutics SA (Non-Executive Director · Since at least Jan 2, 2024); Viela Bio Inc (Director · Oct 2, 2019 – Mar 15, 2021 · Past); PhaseBio Pharmaceuticals Inc (Director · Oct 17, 2018 – Oct 17, 2018 · Past)
Director · May 16, 2017 – May 16, 2017 · Past
Christy L Shaffer
Other companies: CalciMedica, Inc. (Director · Sep 24, 2020 – Mar 23, 2023 · Past); Clearside Biomedical Inc (Director · Jun 1, 2016 – Jun 20, 2024 · Past)
Director · May 16, 2017 – Nov 30, 2017 · Past
Cynthia L. Flowers
Other companies: Lisata Therapeutics, Inc. (Director · Since at least Nov 7, 2018); Kadmon Holdings Inc (Director · Jan 22, 2019 – Nov 8, 2021 · Past)
Director · Jun 7, 2018 – Sep 18, 2024 · Past
Jacks Lee
Other companies: Vaxcyte, Inc. (Director · Since at least Nov 27, 2023)
Director · Jun 27, 2022 – Sep 18, 2024 · Past
James S Hanson
Other companies: Fortrea Holdings Inc. (General Counsel · Since at least Jun 9, 2023)
General Counsel · Jun 25, 2018 – Jan 3, 2023 · Past
Jennifer K Moses
Other companies: Viridian Therapeutics, Inc. (Director · Since at least Jul 14, 2021)
CFO · Jan 2, 2018 – Jan 3, 2023 · Past
All 18 people
PersonSeat
Mark A. Velleca
Other companies: Black Diamond Therapeutics, Inc. (Chief Executive Officer · Since at least Aug 9, 2021)
Director · May 16, 2017 – Aug 8, 2023 · Past
Andrew PerryChief Commercial Officer · Aug 16, 2021 – Sep 18, 2024 · Past
Gregory J MossinghoffChief Business Officer · May 16, 2017 – May 16, 2017 · Past
John E Bailey JrPresident and CEO, Director · Mar 12, 2020 – Sep 18, 2024 · Past
John W V UmsteadChief Financial Officer · Mar 15, 2023 – Sep 18, 2024 · Past
Mark AvaglianoChief Business Officer · Jul 29, 2019 – Sep 18, 2024 · Past
Norman SharplessDirector · Jul 22, 2022 – Sep 18, 2024 · Past
Soma GuptaChief Commercial Officer · Mar 31, 2020 – Jan 4, 2021 · Past

Open People

Log in to ask 6ix AI your own questions about G1 Therapeutics Inc.